AlzeCure Pharma AB
ALZCUR
ALZCUR
Insider Trading Activity
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-08-26 | 2025-08-25 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
49,379
183.43
SEK4,980,909 |
49,379 | 183.43 | SEK4,980,909 | |
| 2025-08-01 | 2025-07-30 | B Purchase |
Other member of the company's administrative, management or supervisory body |
87,840
453.36
SEK1,919,422 |
87,840 | 453.36 | SEK1,919,422 | |
| 2025-07-29 | 2025-07-29 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
89,430
379.34
SEK3,478,928 |
89,430 | 379.34 | SEK3,478,928 | |
| 2025-07-28 | 2025-07-28 | B Purchase |
Other member of the company's administrative, management or supervisory body |
4,545
2.20
SEK9,999 |
4,545 | 2.20 | SEK9,999 | |
| 2025-07-27 | 2025-07-25 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
178,549
2.20
SEK392,808 |
178,549 | 2.20 | SEK392,808 | |
| 2025-07-31 | 2025-07-24 | B Purchase |
Member of the Board of Directors Director |
150,000
2.20
SEK330,000 |
150,000 | 2.20 | SEK330,000 | |
| 2025-07-26 | 2025-07-23 | B Purchase |
Other senior executive Officer |
22,727
2.20
SEK49,999 |
22,727 | 2.20 | SEK49,999 | |
| 2025-07-25 | 2025-07-23 | B Purchase |
Chairman of the Board of Directors Director |
568,030
2.20
SEK1,249,666 |
568,030 | 2.20 | SEK1,249,666 | |
| 2025-07-26 | 2025-07-17 | S Sale |
Other senior executive Officer |
500,000
0.15
SEK75,000 |
500,000 | 0.15 | SEK75,000 | |
| 2025-07-26 | 2025-07-17 | S Sale |
Other senior executive Officer |
500,000
0.15
SEK75,000 |
500,000 | 0.15 | SEK75,000 | |
| 2024-05-29 | 2024-05-28 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
100,000
1.70
SEK170,000 |
100,000 | 1.70 | SEK170,000 | |
| 2024-05-23 | 2024-05-20 | B Purchase |
Member of the Board of Directors Director |
12,500
1.70
SEK21,250 |
12,500 | 1.70 | SEK21,250 | |
| 2024-05-24 | 2024-05-17 | B Purchase |
Other member of the company's administrative, management or supervisory body |
37,083
1.70
SEK63,041 |
37,083 | 1.70 | SEK63,041 | |
| 2024-05-21 | 2024-05-17 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
121,433
1.70
SEK206,436 |
121,433 | 1.70 | SEK206,436 | |
| 2024-05-21 | 2024-05-17 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
83,300
1.70
SEK141,610 |
83,300 | 1.70 | SEK141,610 | |
| 2024-05-21 | 2024-05-17 | B Purchase |
Other member of the company's administrative, management or supervisory body |
44,500
1.70
SEK75,650 |
44,500 | 1.70 | SEK75,650 | |
| 2024-05-20 | 2024-05-17 | B Purchase |
Member of the Board of Directors Director |
12,500
1.70
SEK21,250 |
12,500 | 1.70 | SEK21,250 | |
| 2024-05-20 | 2024-05-17 | B Purchase |
Chairman of the Board of Directors Director |
320,833
1.70
SEK545,416 |
320,833 | 1.70 | SEK545,416 | |
| 2024-05-20 | 2024-05-17 | B Purchase |
Chairman of the Board of Directors Through Oncolution AB, a closely affiliated person Director |
429,813
1.70
SEK730,682 |
429,813 | 1.70 | SEK730,682 | |
| 2024-05-20 | 2024-05-17 | B Purchase |
Chief Financial Officer (CFO) Through Enable - Finance & Business Development in Sweden AB, a closely affiliated person Officer |
8,750
1.70
SEK14,875 |
8,750 | 1.70 | SEK14,875 |
More insider trading research around AlzeCure Pharma AB
